Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,842 | 22,450 | 7,092 | 10,615 | 13,302 |
| TOTAL | $19,803 | $23,044 | $7,863 | $11,386 | $14,752 |
| Non-Current Assets | |||||
| PPE Net | 375 | 411 | 412 | 435 | 462 |
| Other Non-Current Assets | 519 | 398 | 414 | 430 | 445 |
| TOTAL | $894 | $809 | $826 | $865 | $907 |
| Total Assets | $20,697 | $23,853 | $8,690 | $12,251 | $15,659 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,839 | 3,207 | 2,941 | 2,664 | 2,875 |
| TOTAL | $3,956 | $3,320 | $3,051 | $2,770 | $2,978 |
| Non-Current Liabilities | |||||
| Long Term Debt | 184 | 184 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 333 | 364 | 393 | 422 | 450 |
| TOTAL | $517 | $548 | $393 | $422 | $450 |
| Total Liabilities | $4,473 | $3,867 | $3,444 | $3,191 | $3,428 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89 | 89 | 31 | 31 | 31 |
| Retained earnings | -123,160 | -119,251 | -115,639 | -111,681 | -108,301 |
| TOTAL | $16,224 | $19,985 | $5,246 | $9,059 | $12,231 |
| Total Liabilities And Equity | $20,697 | $23,853 | $8,690 | $12,251 | $15,659 |